9032 related articles for article (PubMed ID: 14666660)
1. 2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice.
Johnson LA; Vaidya SV; Goldfarb RH; Mathew PA
Anticancer Res; 2003; 23(5A):3651-5. PubMed ID: 14666660
[TBL] [Abstract][Full Text] [Related]
2. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
[TBL] [Abstract][Full Text] [Related]
3. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
[TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.
Vaidya SV; Stepp SE; McNerney ME; Lee JK; Bennett M; Lee KM; Stewart CL; Kumar V; Mathew PA
J Immunol; 2005 Jan; 174(2):800-7. PubMed ID: 15634901
[TBL] [Abstract][Full Text] [Related]
6. 2B4-mediated activation of human natural killer cells.
Tangye SG; Cherwinski H; Lanier LL; Phillips JH
Mol Immunol; 2000 Jun; 37(9):493-501. PubMed ID: 11163399
[TBL] [Abstract][Full Text] [Related]
7. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
[TBL] [Abstract][Full Text] [Related]
8. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.
Lee KM; McNerney ME; Stepp SE; Mathew PA; Schatzle JD; Bennett M; Kumar V
J Exp Med; 2004 May; 199(9):1245-54. PubMed ID: 15123744
[TBL] [Abstract][Full Text] [Related]
9. 2B4/CD48-mediated regulation of lymphocyte activation and function.
Assarsson E; Kambayashi T; Persson CM; Chambers BJ; Ljunggren HG
J Immunol; 2005 Aug; 175(4):2045-9. PubMed ID: 16081768
[TBL] [Abstract][Full Text] [Related]
10. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
Chuang SS; Kumaresan PR; Mathew PA
J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
[TBL] [Abstract][Full Text] [Related]
11. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
Vaidya SV; Mathew PA
Immunol Lett; 2006 Jun; 105(2):180-4. PubMed ID: 16621032
[TBL] [Abstract][Full Text] [Related]
12. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
Messmer B; Eissmann P; Stark S; Watzl C
J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand.
Sinha SK; Gao N; Guo Y; Yuan D
J Immunol; 2010 Nov; 185(9):5205-10. PubMed ID: 20881194
[TBL] [Abstract][Full Text] [Related]
14. 2B4 inhibits NK-cell fratricide.
Taniguchi RT; Guzior D; Kumar V
Blood; 2007 Sep; 110(6):2020-3. PubMed ID: 17537992
[TBL] [Abstract][Full Text] [Related]
15. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
[TBL] [Abstract][Full Text] [Related]
16. Activating interactions in human NK cell recognition: the role of 2B4-CD48.
Nakajima H; Cella M; Langen H; Friedlein A; Colonna M
Eur J Immunol; 1999 May; 29(5):1676-83. PubMed ID: 10359122
[TBL] [Abstract][Full Text] [Related]
17. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4.
Boles KS; Nakajima H; Colonna M; Chuang SS; Stepp SE; Bennett M; Kumar V; Mathew PA
Tissue Antigens; 1999 Jul; 54(1):27-34. PubMed ID: 10458320
[TBL] [Abstract][Full Text] [Related]
19. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG; Phillips JH; Lanier LL; Nichols KE
J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
[TBL] [Abstract][Full Text] [Related]
20. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
